Jump to main content
Jump to site search

Issue 6, 2018
Previous Article Next Article

Cyclotriphosphazene core-based dendrimers for biomedical applications: an update on recent advances

Author affiliations

Abstract

This review is focused on the recent use of cyclotriphosphazene-based dendrimers in biomedicine. Since its synthesis for the first time in 1834, cyclotriphosphazene has been an important compound of phosphorus chemistry as a scaffold, and a large number of cyclotriphosphazene derivatives have been synthesized and applied in various fields such as biology, catalysis, fluorescence, nanomaterials, etc. Today, one of the most important uses concerns its biomedical applications. In this review, the recent developments (since 2012) of cyclotriphosphazene for major pharmaceutical applications are highlighted and analyzed.

Graphical abstract: Cyclotriphosphazene core-based dendrimers for biomedical applications: an update on recent advances

Back to tab navigation

Publication details

The article was received on 28 Nov 2017, accepted on 11 Jan 2018 and first published on 11 Jan 2018


Article type: Review Article
DOI: 10.1039/C7TB03081A
Citation: J. Mater. Chem. B, 2018,6, 884-895
  •   Request permissions

    Cyclotriphosphazene core-based dendrimers for biomedical applications: an update on recent advances

    L. Wang, Y. Yang, X. Shi, S. Mignani, A. Caminade and J. Majoral, J. Mater. Chem. B, 2018, 6, 884
    DOI: 10.1039/C7TB03081A

Search articles by author

Spotlight

Advertisements